STUB1 and non-small cell lung carcinoma: To understand the interplay between ICI and CHIP in NSCLC patients, we conducted CHIP-targeted panel sequencing and single-cell RNA sequencing (scRNA-seq) on blood samples collected before and 1–3 weeks after ICI administration.